WIDMApp
The Molecular Radionuclide Therapy is based on the delivery of ionizing radiation to malignant tissues through a radiopharmaceutical. The precise calculation of the absorbed dose to tumor and normal tissues is essential to increase therapeutic effectiveness, optimize treatment planning and establish dose-effect relationships. WIDMApp determines the biokinetics expressed by the patient with a new approach that combines in a cutting-edge apparatus: a wearable multichannel device for in-vivo radiation detection, a complete individual modelling of the radiation propagation in the patient anatomy, and a sophisticated data analysis toolkit.
The detecting elements, based on the simple and compact scintillator technology, are embedded in biocompatible e-textile materials allowing for a fully integrated system that the patient comfortably wears during the entire treatment. While the device monitors activity accumulation and clearance in the body, a custom algorithm analyses the data, deconvolves the detected signals in contributions from the emitting volumes, and reconstructs the retention curve proper of each organ/lesion.
More information on the project can be found in the following Medical Physics publication.Websites:
- in preparation
Thesis Opportunities:
For information, please contact: Francesco Collamati.Local Coordinator
Francesco Collamati| Name | Surname | Role | Position |
|---|---|---|---|
| Francesco | Collamati | Dipendente | Ricercatore |
| Silvio | Morganti | Dipendente | Primo Ricercatore |
| Riccardo | Faccini | Associato | Prof. Ordinario |
| Riccardo | Mirabelli | Associato | Assegnista |